BioCentury
ARTICLE | Company News

Cubist receives option to acquire Adynxx

February 26, 2013 1:32 AM UTC

Cubist Pharmaceuticals Inc. (NASDAQ:CBST) received an exclusive option to acquire Adynxx Inc. (San Francisco, Calif.) following data from a Phase II trial of Adynxx's lead candidate, AYX1. Adynxx will...